Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines

• Fares Elghali,
• Dhouha Msalbi,
• Fakher Frikha,
• Mona Alonazi,
• Emna Sahli,
• Bochra Hakim,
• Sami Mnif,
• Abir Ben Bacha,
• Sami Aifa

Affiliations

Fares Elghali

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia

Dhouha Msalbi

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia

Fakher Frikha

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia

Mona Alonazi

Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia

Emna Sahli

Unity of Analysis, Centre of Biotechnology of Sfax, Sfax, Tunisia

Bochra Hakim

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia

Sami Mnif

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia

Abir Ben Bacha

Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia

Sami Aifa

Laboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia